Search clinical trials for: Dutasteride placebo

Total 53556 results

GlaxoSmithKline

Completed

Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia

Androgenetic Alopecia

Japan, Argentina, Peru, Philippines, Taiwan, Mexico, Chile, Russian Federation, Thailand
GlaxoSmithKline

Completed

Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)

Prostatic Hyperplasia | Benign Prostatic Hyperplasia

China
UConn Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Active, not recruiting

Dutasteride Treatment for Reducing Heavy Drinking in AUD: Predictors of Efficacy

Alcohol Use Disorder

United States
Northwestern University
GlaxoSmithKline

Terminated

A Clinical Trial Comparing Laser TURP With and Without Dutasteride.

Benign Prostatic Hyperplasia
UConn Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institutes...

Completed

Pharmacogenetics of Alcohol: Treatment Implications

Alcoholism | Alcohol Related Disorders | Alcohol Abuse

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...
National Cancer Institute (NCI)

Completed

Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer

Prostate Cancer

United States
GlaxoSmithKline

Completed

Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia

Prostatic Hyperplasia

Korea, Republic of, China, Japan, Taiwan
GlaxoSmithKline

Completed

A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry. (ARI114694)

Prostatic Hyperplasia

Australia
Ain Shams University

Completed

Role of Dutasteride in Treatment of Chronic Prostatitis

Dutasteride | Category IIIB Chronic Prostatitis

Egypt
Bio-innova Co., Ltd

Not yet recruiting

Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule

Healthy Subjects
Bay State Clinical Trials, Inc.
GlaxoSmithKline

Completed

Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation

Prostate Cancer

United States
University of Washington
GlaxoSmithKline; VA Office of Research and Development; Seattle Institute for... and other collaborators

Completed

TRADE-Testosterone Replacement and Dutasteride Effectiveness (TRADE)

Benign Prostatic Hyperplasia | Hypogonadism

United States
Dongkook Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Korea, Republic of
GlaxoSmithKline

Completed

Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy

Neoplasms, Prostate

United States, Canada
GlaxoSmithKline

Completed

Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects

Prostatic Hyperplasia

Japan
GlaxoSmithKline

Completed

Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjects (ARI115148)

Prostatic Hyperplasia

United States
Seoul National University Hospital
GlaxoSmithKline; The Korean Urological Association

Completed

Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate

Benign Prostatic Hyperplasia
GlaxoSmithKline

Completed

ARI103094-Follow-Up Study for REDUCE Study Subjects

Neoplasms, Prostate

France, Germany, Spain, United States, Netherlands, Canada, United Kingdom, Finland, Chile, Sweden, Argentina, Greece
Urology of Virginia
GlaxoSmithKline

Unknown

Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United States
The Miriam Hospital
GlaxoSmithKline

Completed

Efficacy Study for Use of Dutasteride (Avodart) With Testosterone Replacement (DUT/T)

Hypogonadism

United States
Corpometria Institute

Completed

EAT-DUTA AndroCoV Trial

Covid19

Brazil
University of California, San Francisco

Completed

MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer

Prostate Cancer | Nonmalignant Neoplasm

United States
Roswell Park Cancer Institute

Completed

Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy

Prostate Cancer

United States
GlaxoSmithKline

Completed

A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia

Prostatic Hyperplasia

Australia
GlaxoSmithKline

Completed

A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia

Alopecia

Japan
Kaunas University of Medicine

Completed

Prevention of Prostate Cancer With Dutasteride in Case of High Grade PIN Neoplasia

Prostate Cancer

Lithuania
GlaxoSmithKline

Completed

A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia

Alopecia
GlaxoSmithKline

Completed

Prospective Sexual Function Study for BPH Subjects

Prostatic Hyperplasia

Germany, Australia, Netherlands, Spain, Hungary, France, Greece
University of Washington
GlaxoSmithKline; AstraZeneca

Completed

Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer (TAPS)

Cancer | Prostate Neoplasms

United States
CHU de Quebec-Universite Laval
Prostate Cancer Canada

Active, not recruiting

Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression

Prostatic Neoplasms | Low Grade Prostate Cancer

Canada
Siami, Paul F., M.D.
GlaxoSmithKline; Pfizer

Completed

Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS) (LUTS)

Benign Prostatic Hyperplasia (BPH)

United States
GlaxoSmithKline

Completed

Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment

Prostatic Hyperplasia

United States, Netherlands, Spain, Taiwan, Bulgaria, Estonia, Hungary, Italy, Belgium, Thailand, Israel, Germany, Canada, Korea, Republic of, Norway, Finland, Russian Federation, Romania, Brazil, France, Slovakia, Philippines, South... and more
Beth Israel Deaconess Medical Center
M.D. Anderson Cancer Center; Massachusetts General Hospital; Sunnybrook Health... and other collaborators

Completed

Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer (KHAD)

Prostate Cancer

United States, Canada
GlaxoSmithKline

Completed

Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride

Hypogonadism | Hypogonadism, Male

United States
GlaxoSmithKline

Completed

Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects

Prostatic Hyperplasia

United States
GlaxoSmithKline

Completed

28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men

Hypogonadism | Hypogonadism, Male

United States
Toni Choueiri, MD

Withdrawn

STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling

Adenocarcinoma of the Prostate

United States
GlaxoSmithKline

Completed

ARTS - AVODART After Radical Therapy For Prostate Cancer Study (ARTS)

Neoplasms, Prostate | Prostate Cancer After a Radical Treatment

Spain, Estonia, Netherlands, United Kingdom, Germany, Finland, France, Russian Federation, Sweden
University of Rochester

Completed

Enzalutamide & Dutasteride/Finasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer.

Prostate Cancer

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia

Alopecia

Korea, Republic of, Taiwan, Singapore, Hong Kong, Chile
Canadian Urology Research Consortium
GlaxoSmithKline

Completed

Comparing 0.5 mg Dutasteride vs Placebo Daily in Men Receiving Androgen Ablation Therapy for Prostate Cancer (AVIAS)

Prostate Cancer

Canada
GlaxoSmithKline

Completed

"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk (REDUCE)

Neoplasms, Prostate

United States, Australia, France, Germany, Spain, Bulgaria, Estonia, Italy, Poland, Netherlands, Belgium, United Kingdom, Canada, Denmark, Ukraine, Finland, Latvia, Russian Federation, Greece, Slovenia, Brazil, Mexico, Slovakia, Japan, Puerto... and more
GlaxoSmithKline

Completed

Bioequivalence - Duodart Against Avodart & Omnic

Prostatic Hyperplasia

Russian Federation
CHU de Quebec-Universite Laval
GlaxoSmithKline

Completed

Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy

Lower Urinary Tract Symptoms | Erectile Dysfunction | Prostate Cancer

Canada
GlaxoSmithKline

Completed

Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in Fed State

Urologic Diseases

United Kingdom
GlaxoSmithKline

Completed

Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database

Prostatic Hyperplasia
Dr. J. Curtis Nickel
University of California, Los Angeles; The Cleveland Clinic

Terminated

JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

Benign Prostatic Hyperplasia | Chronic Prostatitis

Canada
Fundacion para la Investigacion Biomedica del Hospital...

Active, not recruiting

Exploratory Clinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia.

Male Androgenetic Alopecia

Spain
University of Illinois at Chicago
National Cancer Institute (NCI)

Completed

Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies

Prostate Cancer

United States
GlaxoSmithKline

Completed

Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males. (ARI115707)

Prostatic Hyperplasia

Australia

Search clinical trials for: Dutasteride placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations